Restricted accessResearch articleFirst published online 2013-12
Massive Dissemination of Methicillin Resistant Staphylococcus aureus in Bloodstream Infections in a High MRSA Prevalence Country: Establishment and Diversification of EMRSA-15
Portugal is the European country with the highest prevalence of methicillin resistant Staphylococcus aureus (MRSA), in which EMRSA-15 (ST22-IVh) has been the dominant clone since soon after its introduction in Portuguese hospitals in 2001. In this study, we intend to not only, assess the evolution of the invasive MRSA in Portuguese hospitals, but also to evaluate the invasive methicillin susceptible S. aureus (MSSA) population and the relationship between both populations. In the current study, two major MRSA clones were identified: EMRSA-15 that has been dominant for more than 10 years and accounts for 75% of the MRSA isolates, and ST105-II, a clone related with the New York/Japan clone (ST5-II). In contrast, among MSSA, several clonal backgrounds were identified. Despite of the massive predominance of EMRSA-15 in the last decade, an increase in spa diversity has been observed in the last few years, which suggests a recent and local diversification of this clone. Interestingly, MRSA and MSSA populations with related clonal backgrounds appear to have increased as a result of the dissemination of MRSA to the community environment.
Get full access to this article
View all access options for this article.
References
1.
AdriaenssensN., CoenenS., VersportenA., MullerA., MinaluG., FaesC.et al.2011. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)J. Antimicrob. Chemother., 66,Suppl 6:vi3–vi12.
2.
AdriaenssensN., CoenenS., VersportenA., MullerA., MinaluG., FaesC.et al.2011. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009)J. Antimicrob. Chemother., 66,Suppl 6:vi47–vi56.
3.
Aires de SousaM., CorreiaB., de LencastreH.2008. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period. J. Clin. Microbiol., 46:2912–2917.
4.
Aires de SousaM., BoyeK., de LencastreH., DeplanoA., EnrightM.C., EtienneJ.et al.2006. igh interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J. Clin. Microbiol., 44:619–621.
5.
Aires de SousaM., ConceicaoT., SimasC., de LencastreH.2005. Comparison of genetic backgrounds of methicillin-resistant and susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community. J. Clin. Microbiol., 43:5150–5157.
6.
AmorimM.L., VasconcelosC., OliveiraD.C., AzevedoA., CaladoE., FariaN.A.et al.2009. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization among patients and healthcare workers in a Portuguese hospital: a pre-intervention study toward the control of MRSA. Microb. Drug Resist., 15:19–26.
7.
AmorimM.L., FariaN.A., OliveiraD.C., VasconcelosC., CabedaJ.C., MendesA.C.et al.2007. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J. Clin. Microbiol., 45:2881–2888.
8.
BerglundC., ItoT., MaX.X., IkedaM., WatanabeS., SoderquistB.et al.2008. Genetic diversity of methicillin-resistant Staphylococcus aureus carrying type IV SCCmec in Orebro County and the western region of Sweden. J. Antimicrob. Chemother., 63:32–41.
9.
BlancD.S., PetignatC., WengerA., KuhnG., ValletY., FracheboudD.et al.2007. Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J. Clin. Microbiol., 45:3729–3736.
10.
BörjessonS., MatussekA., MelinS., LöfgrenS., LindgrenP.E.2010. Methicillin-resistant Staphylococcus aureus (MRSA) in municipal wastewater: an uncharted threat?J. Appl. Microbiol., 108:1244–1251.
11.
Caiaffa-FilhoH.H., TrindadeP.A., Gabriela da CunhaP., AlencarC.S., PradoG.V.B., RossiF.et al.2013. Methicillin-resistant Staphylococcus aureus carrying SCCmec type II was more frequent than the Brazilian endemic clone as a cause of nosocomial bacteremia. Diagn. Microbiol. Infect. Dis., 76:518–520.
12.
ConceicaoT., Aires de SousaM., PonaN., BritoM.J., BarradasC., CoelhoR.et al.2011. High prevalence of ST121 in community-associated methicillin-susceptible Staphylococcus aureus lineages responsible for skin and soft tissue infections in Portuguese children. Eur. J. Clin. Microbiol. Infect. Dis., 30:293–297.
13.
CrisostomoM.I., WesthH., TomaszA., ChungM., OliveiraD.C., de LencastreH.2001. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. U. S. A., 98:9865–9870.
14.
D'SouzaN., RodriguesC., MehtaA.2010. Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J. Clin. Microbiol., 48:1806–1811.
15.
DasS., AndersonC.J., GrayesA., MendozaK., HarazinM., SchoraD.M.et al.2013. Nasal carriage of epidemic methicillin-resistant Staphylococcus aureus -15 (EMRSA-15) observed in three Chicago-area long term care facilities. Antimicrob. Agents Chemother., 57:4551.
16.
DavidM.Z., Boyle-VavraS., ZychowskiD.L., DaumR.S.2011. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles?PLoS ONE, 6:e18217.
17.
EARSS. 2011. European Antimicrobial Resistance Surveillance System 2011November2012. www.earss.rivm.nl. (Online.)
18.
EnrightM.C., DayN.P., DaviesC.E., PeacockS.J., SprattB.G.2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol., 38:1008–1015.
19.
EspadinhaD., FariaN.A., MiragaiaM., LitoL.M., Melo CristinoJ., de LencastreH.et al.2013. Extensive dissemination of methicillin-resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA. PLoS ONE, 8:e59960.
20.
Ghaznavi-RadE., ShamsudinM.N., SekawiZ., KhoonL.Y., AzizM.N., HamatR.A.et al.2010. Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J. Clin. Microbiol., 48:867–872.
21.
Goncalves-PereiraJ., PovoaP.R., LoboC., CarneiroA.H.2013. Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study)Clin. Microbiol. Infect., 19:242–248.
22.
GrundmannH., AanensenD.M., van den WijngaardC.C., SprattB.G., HarmsenD., FriedrichA.W.et al.2010. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med., 7:e1000215.
23.
HarbarthS., RutschmannO., SudreP., PittetD.1998. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch. Intern. Med., 158:182–189.
24.
HarmsenD., ClausH., WitteW., RothgangerJ., TurnwaldD., VogelU.2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol., 41:5442–5448.
25.
HoldenM.T.G., HsuL.-Y., KurtK., WeinertL.A., MatherA.E., HarrisS.R.et al.2013. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res., 23:653–664.
26.
ItoT., MaX.X., TakeuchiF., OkumaK., YuzawaH., HiramatsuK.2004. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother., 48:2637–2651.
27.
JohnsonA.P., AuckenH.M., CavendishS., GannerM., WaleM.C., WarnerM.et al.2001. Dominance of EMRSA-15 and-16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)J. Antimicrob. Chemother., 48:143–144.
28.
KoreenL., RamaswamyS.V., GravissE.A., NaidichS., MusserJ.M., KreiswirthB.N.2004. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol., 42:792–799.
29.
LinaG., PiemontY., Godail-GamotF., BesM., PeterM.O., GauduchonV.et al.1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis., 29:1128–1132.
30.
Melo CristinoJ., ResinaC., ManuelV., LitoL., RamirezM.2013. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet, 382:205.
31.
MilheiriçoC., OliveiraD.C., de LencastreH.2007. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: “SCCmecIV multiplex.”J. Antimicrob. Chemother., 60:42–48.
32.
MilheiriçoC., OliveiraD.C., de LencastreH.2007. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob. Agents Chemother., 51:3374–3377.
33.
MillerL.G., Perdreau-RemingtonF., BayerA.S., DiepB., TanN., BharadwaK.et al.2007. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin. Infect. Dis., 44:471–482.
34.
MollaghanA.M., LuceyB., CoffeyA., CotterL.2010. Emergence of MRSA clone ST22 in healthy young adults in the community in the absence of risk factors. Epidemiol. Infect., 138:673–676.
35.
OkumaK., IwakawaK., TurnidgeJ.D., GrubbW.B., BellJ.M., O'BrienF.G.et al.2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol., 40:4289–4294.
36.
OliveiraD.C., de LencastreH.2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 46:2155–2161.
37.
PinaE., PaivaJ.A., NogueiraP., SilvaM.G.2013. Prevalência de infeção adquirida no hospital e do uso de antimicrobianos nos hospitais Portugueses—Inquérito 2012. Direção-Geral da SaúdeMinistério da Saúde (In Portuguese).
SelveyL.A., WhitbyM., JohnsonB.2000. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?Infect. Control Hosp. Epidemiol., 21:645–648.
40.
SimoesR.R., Aires de SousaM., ConceicaoT., AntunesF., da CostaP.M., de LencastreH.2011. High prevalence of EMRSA-15 in Portuguese public buses: a worrisome finding. PLoS ONE, 6:e17630.
41.
SimpsonE.H.1949. Measurement of species diversity. Nature, 163:688.
42.
TavaresA., MiragaiaM., RoloJ., CoelhoC., de LencastreH., groupC.-M.M.W.2013. High prevalence of hospital-associated methicillin-resistant Staphylococcus aureus in the community in Portugal: evidence for the blurring of community-hospital boundaries. Eur. J. Clin. Microbiol. Infect. Dis., 32:1269–1283.
43.
Torres-SangiaoE., Perez-CastroS., Fernandez-NatalM.I., Cisterna-CancerR., Zapico-GonzalezM., Fernandez-PerezB.et al.2012. Identification of international circulating lineages of meticillin-resistant Staphylococcus aureus in the north of Spain and their glycopeptide and linezolid susceptibility. J. Med. Microbiol., 61:305–307.
